A case of ulcerative jejunoileitis treated with anti tumor necrosis factor-alpha antibodies [2]

Panminerva Medica

Volumn 47, Issue 4, 2005, Pages 269-272

  Gaia, S ^a   Bruno, M ^a   Marzano, A ^a   Novero, D ^a   Astegiano, M ^a   Actis, G C ^a   Rizzetto, M ^a  

^a MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

CASE REPORT; CELIAC DISEASE; DRUG ANTAGONISM; DUODENUM; HUMAN; ILEITIS; JEJUNUM DISEASE; LETTER; MALE; MIDDLE AGED; PATHOLOGY;

ANTIBODIES, MONOCLONAL; CELIAC DISEASE; DUODENUM; HUMANS; ILEITIS; JEJUNAL DISEASES; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33645277364     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Tracey KJ, Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med 1994;45:491-503.
2. Stuber E, Buschenfeld A, von Freier A, Arendt T, Folsch UR. Intestinal crypt cell apoptosis in murine acute graft versus host disease is mediated by tumor necrosis factor alpha and not by the FasL-Fas interaction: effect of pentoxifylline on the development of mucosal atrophy. Gut 1999;45:229-35.
3. Gillett HR, Arnott IDR, McIntyre M, Campbell S, Dahele A, Priest M et al. Successful infliximab treatment for steroid-refractory celiac disease: a case report. Gastroenterology 2002;122:800-5.
4. Brown SL, Greene MH, Gershon SK, Edwards ET, Braun MM. Tumor necrosis factor antagonist therapy and lymphoma development. Arthritis Rheum 2002;46:3151-8.
5. Bickston SJ, Lichtenstein GR, Arseneau KO, Cohen RB, Cominelli F. The relationship between infliximab treatment and lymphoma in Crohn's disease. Gastroenterology 1999;117:1433-7.